Antibodies Assay Kits Bap1 Antibody Biology Cells Brd4 Antibody Gels Glut2 Antibody Hama Antibodies Isotypes Laminin Alpha 5 PCR Ria Kits RNA Stat5 Antibody Tcf4 Antibody Tgf Alpha Elisa Vi Alpha Vitronectin Antibody Western Blot Zebrafish Antibodies
Human genetics and its impact on cardiovascular disease
Heart problems (CVD) is a significant reason behind demise worldwide. Provided that CVD is a extremely heritable trait, researchers have tried to totally perceive the genetic foundation of CVD for a very long time. The human genome contains 3,100 Mbp per haploid genome and 6,200 Mbp in whole (diploid genome).
Nevertheless, there’s a tendency for uncommon genetic variations to exhibit a big impact measurement, whereas widespread genetic variations have a small impact on illnesses, due to pure choice. On this sense, dividing genetic variations into two teams primarily based on allele frequency (and impact sizes on illnesses) is a good suggestion.
We all know there are a number of vital genes (particularly lipid-related genes) by which uncommon genetic variations are apparently related to CVD danger, whereas a polygenic danger rating comprising widespread genetic variations seems to work fairly nicely amongst normal populations.
That info can be utilized not just for danger stratification but in addition for discoveries for novel pharmacologic targets. On this evaluate article, we offer the vital and easy concept that human genetics is vital for CVD as a result of it’s a extremely heritable trait, and we consider that it’ll result in precision drugs on this subject.
Human genetic and immunological dissection of papillomavirus-driven illnesses: new insights into their pathogenesis
Human papillomaviruses (HPVs) are chargeable for cutaneous and mucosal lesions. Persistent HPV an infection stays a number one reason behind uterine most cancers in girls, but in addition of cutaneous squamous cell carcinoma in sufferers with epidermodysplasia verruciformis (EV), and of uncommon and devastating benign tumors, akin to ‘tree-man’ syndrome.
HPV infections are normally asymptomatic or benign within the normal inhabitants. Extreme manifestations in in any other case wholesome topics can attest to inherited immunodeficiencies. The human genetic dissection of those instances has recognized vital elements of the immune response to HPVs, together with the non-redundant roles of keratinocyte-intrinsic immunity in controlling β-HPVs, and of T cell-dependent adaptive immunity for controlling all HPV varieties.
A key position of the CD28 T-cell costimulation pathway in controlling widespread warts on account of HPVs was just lately found. This evaluate summarizes the state-of-the-art within the human genetics of HPV an infection, specializing in two key affected cell varieties: keratinocytes and T cells.
Genetic traits of human papillomavirus kind 16, 18, 52 and 58 in southern China
Persistent infections of high-risk human papillomaviruses (HPVs) are the main reason behind cervical cancers. We collected cervical exfoliated cell samples from females in Changsha metropolis, Hunan Province and obtained 358 viral genomes of 4 main HPV varieties, together with HPV 16 (n = 82), 18 (n = 35), 52 (n = 121) and 58 (n = 100).
The lineage/sublineage distribution of the 4 HPVs confirmed earlier epidemiological reviews, with the predominant prevailing sublineage as A4 (50%), A1 (37%) and A3 (13%) for HPV16, A1 (83%) for HPV18, B2 (86%) for HPV52 and A1 (65%), A3 (19%) and A2 (12%) for HPV58. We additionally recognized two probably novel HPV18 sublineages, i.e. A6 and A7.
Virus mutation evaluation additional revealed the presence of HPV16 and HPV58 sublineages related to probably excessive oncogenicity. These findings expanded our data on the HPV genetic variety in China, offering worthwhile proof to facilitate HPV DNA screening, vaccine effectiveness analysis and management technique growth.
A inhabitants genetic perspective on the origin, unfold and adaptation of the human malaria brokers Plasmodium falciparum and Plasmodium vivax
Malaria is taken into account one of the crucial vital scourges that humanity has confronted throughout its historical past, being accountable yearly for quite a few deaths worldwide. The illness is attributable to protozoan parasites, amongst which two species are accountable of the vast majority of the burden, Plasmodium falciparum and Plasmodium vivax.
For these two parasite species, the questions of their origin (how and once they appeared in people), of their unfold all through the world, in addition to how they’ve tailored to people have lengthy been of curiosity to the scientific group.
Right here, we evaluate the present data that has amassed on these completely different questions, thanks specifically to the evaluation of the genetic and genomic variability of those parasites and comparability with associated Plasmodium species infecting different host species (like non-human primates). On this paper we evaluate the present physique of information,
together with present analysis coping with these questions, focusing notably on genetic evaluation and genomic variability of those parasites and comparability with associated Plasmodium species infecting different species of host (akin to non-human primates).
Streptococcus pneumoniae serotypes that continuously colonise the human nasopharynx are widespread recipients of penicillin-binding protein gene fragments from Streptococcus mitis
Streptococcus pneumoniae is a vital world pathogen that causes bacterial pneumonia, sepsis and meningitis. Beta-lactam antibiotics are the first-line therapy for pneumococcal illness, nonetheless, their effectiveness is hampered by beta-lactam resistance facilitated by horizontal genetic switch (HGT) with intently associated species.
Though interspecies HGT is thought to happen among the many species of the genus Streptococcus, the charges and results of HGT between Streptococcus pneumoniae and its shut family members involving the penicillin binding protein (pbp) genes stay poorly understood.
Right here we utilized the fastGEAR instrument to analyze interspecies HGT in pbp genes utilizing a world assortment of whole-genome sequences of Streptococcus mitis, Streptococcus oralis and S. pneumoniae. With these information, we established that pneumococcal serotypes 6A, 13, 14, 16F, 19A, 19F, 23F and 35B had been the highest-ranking serotypes with acquired pbp fragments. S. mitis was a extra frequent pneumococcal donor of pbp fragments and a supply of upper pbp nucleotide variety compared with S. oralis. Pneumococci that acquired pbp fragments had been related to the next minimal inhibitory focus (MIC) for penicillin in contrast with pneumococci with out acquired fragments.
) Genome polyprotein Antibody (FITC) |
|||
| 20-abx107678 | Abbexa |
|
|
) Genome polyprotein Antibody (HRP) |
|||
| 20-abx109095 | Abbexa |
|
|
Genome polyprotein Antibody (HRP) |
|||
| 20-abx300968 | Abbexa |
|
|
Genome polyprotein Antibody (FITC) |
|||
| 20-abx300969 | Abbexa |
|
|
) Genome polyprotein Antibody (Biotin) |
|||
| 20-abx300970 | Abbexa |
|
|
 Genome Polyprotein Polyclonal Antibody |
|||
| A56130 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody |
|||
| A56743 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody |
|||
| A68253 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody |
|||
| A68254 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: reagents widely cited |
|||
 Hepatitis C Genome polyprotein |
|||
| 1-CSB-RP184674Ba | Cusabio |
|
|
|
Description: Recombinant Hepatitis C Genome polyprotein expressed in E.coli |
|||
 Genome polyprotein Antibody, HRP conjugated |
|||
| 1-CSB-PA333180LB01HFD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
 Genome polyprotein Antibody, FITC conjugated |
|||
| 1-CSB-PA333180LC01HFD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
 Genome polyprotein Antibody, Biotin conjugated |
|||
| 1-CSB-PA333180LD01HFD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, HRP conjugated |
|||
| 1-CSB-PA714772LB01HYH | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, FITC conjugated |
|||
| 1-CSB-PA714772LC01HYH | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, Biotin conjugated |
|||
| 1-CSB-PA714772LD01HYH | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, HRP conjugated |
|||
| 1-CSB-PA18549B0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, FITC conjugated |
|||
| 1-CSB-PA18549C0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, Biotin conjugated |
|||
| 1-CSB-PA18549D0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, HRP conjugated |
|||
| 1-CSB-PA362073LB01HQD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, FITC conjugated |
|||
| 1-CSB-PA362073LC01HQD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody, Biotin conjugated |
|||
| 1-CSB-PA362073LD01HQD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
 Enterovirus 71 Genome polyprotein Antibody |
|||
| 20-abx109758 | Abbexa |
|
|
 Antibody) Genome Polyprotein (HCV-Core) Antibody |
|||
| 33487-05111 | AssayPro | 150 ug | EUR 261 |
 Human rhinovirus 1A Genome polyprotein |
|||
| 1-CSB-YP326367HQA | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus 1A Genome polyprotein,partial expressed in Yeast |
|||
 Japanese encephalitis virus Genome polyprotein |
|||
| 1-CSB-EP189574Ba | Cusabio |
|
|
|
Description: Recombinant Japanese encephalitis virus Genome polyprotein,partial expressed in E.coli |
|||
 Yellow fever virus Genome polyprotein |
|||
| 1-CSB-EP365905YAC1 | Cusabio |
|
|
|
Description: Recombinant Yellow fever virus Genome polyprotein,partial expressed in E.coli |
|||
) Enterovirus 71 Genome polyprotein Antibody (FITC) |
|||
| 20-abx106801 | Abbexa |
|
|
) Enterovirus 71 Genome polyprotein Antibody (HRP) |
|||
| 20-abx108220 | Abbexa |
|
|
) Enterovirus 71 Genome polyprotein Antibody (Biotin) |
|||
| 20-abx105382 | Abbexa |
|
|
 Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
| A56131 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
 Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
| A56132 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: kits suitable for this type of research |
|||
 Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
| A56133 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: fast delivery possible |
|||
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
| A56744 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
| A56745 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: kits suitable for this type of research |
|||
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
| A56746 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: fast delivery possible |
|||
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
| A68250 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: reagents widely cited |
|||
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
| A68251 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
| A68252 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
Genome Polyprotein Polyclonal Antibody, HRP Conjugated |
|||
| A68255 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: Ask the seller for details |
|||
Genome Polyprotein Polyclonal Antibody, FITC Conjugated |
|||
| A68256 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
Genome Polyprotein Polyclonal Antibody, Biotin Conjugated |
|||
| A68257 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: kits suitable for this type of research |
|||
 Rhinovirus A serotype 89 Genome polyprotein Antibody |
|||
| 20-abx109372 | Abbexa |
|
|
 Antibody (Biotin Conjugate)) Genome Polyprotein (HCV-Core) Antibody (Biotin Conjugate) |
|||
| 33487-05121 | AssayPro | 150 ug | EUR 369 |
) Rhinovirus A serotype 89 Genome polyprotein Antibody (FITC) |
|||
| 20-abx107303 | Abbexa |
|
|
) Rhinovirus A serotype 89 Genome polyprotein Antibody (HRP) |
|||
| 20-abx108723 | Abbexa |
|
|
 AssayLite Antibody (FITC Conjugate)) Genome Polyprotein (HCV-Core) AssayLite Antibody (FITC Conjugate) |
|||
| 33487-05141 | AssayPro | 150 ug | EUR 428 |
 AssayLite Antibody (RPE Conjugate)) Genome Polyprotein (HCV-Core) AssayLite Antibody (RPE Conjugate) |
|||
| 33487-05151 | AssayPro | 150 ug | EUR 428 |
 AssayLite Antibody (APC Conjugate)) Genome Polyprotein (HCV-Core) AssayLite Antibody (APC Conjugate) |
|||
| 33487-05161 | AssayPro | 150 ug | EUR 428 |
 AssayLite Antibody (PerCP Conjugate)) Genome Polyprotein (HCV-Core) AssayLite Antibody (PerCP Conjugate) |
|||
| 33487-05171 | AssayPro | 150 ug | EUR 471 |
 Hepatitis C virus genotype 1b Genome polyprotein |
|||
| 1-CSB-YP530838HVQ(A3) | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
|||
Hepatitis C virus genotype 1b Genome polyprotein |
|||
| 1-CSB-YP530838HVQ(A4) | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
|||
 Human rhinovirus A serotype 89 Genome polyprotein |
|||
| 1-CSB-YP362073HQD | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in Yeast |
|||
 Hepatitis C virus genotype 1a Genome polyprotein |
|||
| 1-CSB-MP333180HFD | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in Mammalian cell |
|||
Hepatitis C virus genotype 1a Genome polyprotein |
|||
| 1-CSB-EP333180HFD | Cusabio |
|
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in E.coli |
|||
Human rhinovirus A serotype 89 Genome polyprotein |
|||
| 1-CSB-EP362073HQD | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
|||
Human rhinovirus A serotype 89 Genome polyprotein |
|||
| 1-CSB-EP362073HQDb0 | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
|||
 Recombinant Human Genome polyprotein, His, Yeast-100ug |
|||
| QP7370-ye-100ug | EnQuireBio | 100ug | EUR 480 |
 Recombinant Human Genome polyprotein, His, Yeast-10ug |
|||
| QP7370-ye-10ug | EnQuireBio | 10ug | EUR 236 |
 Recombinant Human Genome polyprotein, His, Yeast-1mg |
|||
| QP7370-ye-1mg | EnQuireBio | 1mg | EUR 1885 |
 Recombinant Human Genome polyprotein, His, Yeast-200ug |
|||
| QP7370-ye-200ug | EnQuireBio | 200ug | EUR 744 |
 Recombinant Human Genome polyprotein, His, Yeast-500ug |
|||
| QP7370-ye-500ug | EnQuireBio | 500ug | EUR 1206 |
 Recombinant Human Genome polyprotein, His, Yeast-50ug |
|||
| QP7370-ye-50ug | EnQuireBio | 50ug | EUR 299 |
 Recombinant Human Genome polyprotein, His-SUMO, E.coli-100ug |
|||
| QP7370-ec-100ug | EnQuireBio | 100ug | EUR 408 |
 Recombinant Human Genome polyprotein, His-SUMO, E.coli-10ug |
|||
| QP7370-ec-10ug | EnQuireBio | 10ug | EUR 200 |
 Recombinant Human Genome polyprotein, His-SUMO, E.coli-1mg |
|||
| QP7370-ec-1mg | EnQuireBio | 1mg | EUR 1632 |
 Recombinant Human Genome polyprotein, His-SUMO, E.coli-200ug |
|||
| QP7370-ec-200ug | EnQuireBio | 200ug | EUR 634 |
 Recombinant Human Genome polyprotein, His-SUMO, E.coli-500ug |
|||
| QP7370-ec-500ug | EnQuireBio | 500ug | EUR 1060 |
 Recombinant Human Genome polyprotein, His-SUMO, E.coli-50ug |
|||
| QP7370-ec-50ug | EnQuireBio | 50ug | EUR 263 |
 Protein) Recombinant JEV Genome polyprotein (aa 2528-3432) Protein |
|||
| VAng-Wyb3447-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 8272 |
|
Description: Japanese encephalitis virus (strain Jaoars982) Genome polyprotein, recombinant protein. |
|||
) Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4793 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3048 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 286-730) |
|||
| VAng-Cr6541-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 903 |
|
Description: YFV Genome polyprotein, partial, recombinant protein. |
|||
) Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2840 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2044 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
Recombinant YFV Genome polyprotein Protein (aa 1-101) |
|||
| VAng-Cr6542-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1411 |
|
Description: YFV Genome polyprotein, recombinant protein. |
|||
 Protein (aa 1-3412)) Recombinant YFV Genome polyprotein (NS4A) Protein (aa 1-3412) |
|||
| VAng-Cr6545-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: YFV (isolate Uganda/A7094A4/1948) Genome polyprotein (NS4A), recombinant protein. |
|||
 Antibody) Gag Polyprotein (gag) Antibody |
|||
| 20-abx318946 | Abbexa |
|
|
Gag Polyprotein (gag) Antibody |
|||
| 20-abx317799 | Abbexa |
|
|
 Antibody) Structural Polyprotein (VP2) Antibody |
|||
| abx224337-100ug | Abbexa | 100 ug | EUR 411 |
 Antibody) Gag Polyprotein (GAG) Antibody |
|||
| abx331332-100ul | Abbexa | 100 ul | EUR 425 |
 Antibody (Biotin)) Gag Polyprotein (GAG) Antibody (Biotin) |
|||
| 20-abx106336 | Abbexa |
|
|
 Antibody (FITC)) Gag Polyprotein (GAG) Antibody (FITC) |
|||
| 20-abx107749 | Abbexa |
|
|
 Antibody (HRP)) Gag Polyprotein (GAG) Antibody (HRP) |
|||
| 20-abx318947 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|||
| 20-abx318948 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (Biotin) |
|||
| 20-abx318949 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (HRP) |
|||
| 20-abx317800 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|||
| 20-abx317801 | Abbexa |
|
|
Gag Polyprotein (GAG) Antibody (Biotin) |
|||
| 20-abx317802 | Abbexa |
|
|
 Sindbis virus Structural polyprotein |
|||
| 1-CSB-CF361018SHZ | Cusabio |
|
|
|
Description: Recombinant Sindbis virus Structural polyprotein,partial expressed in in vitro E.coli expression system |
|||
Sindbis virus Structural polyprotein |
|||
| 1-CSB-CF361018SHZb2 | Cusabio |
|
|
|
Description: Recombinant Sindbis virus Structural polyprotein,partial expressed in in vitro E.coli expression system |
|||
 Turnip mosaic virus Polyprotein |
|||
| 1-CSB-EP2708TJM | Cusabio |
|
|
|
Description: Recombinant Turnip mosaic virus Polyprotein,partial expressed in E.coli |
|||
 Recombinant CHIKV Structural Polyprotein |
|||
| VAng-Lsx0030-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: CHIKV Structural Polyprotein, recombinant protein from E. coli. |
|||
 Antibody) Non-Structural Polyprotein Porf1 (ORF1) Antibody |
|||
| 20-abx300971 | Abbexa |
|
|
 PARK2-/-) Genome edited iPSCs (KO) PARK2-/- |
|||
| ASE-9400 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
 PARK7-/-) Genome edited iPSCs (KO) PARK7-/- |
|||
| ASE-9401 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
 PINK1-/-) Genome edited iPSCs (KO) PINK1-/- |
|||
| ASE-9402 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
 LRRK2-/-) Genome edited iPSCs (KO) LRRK2-/- |
|||
| ASE-9403 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
 BDNF-/-) Genome edited iPSCs (KO) BDNF-/- |
|||
| ASE-9404 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
 APOE-/-) Genome edited iPSCs (KO) APOE-/- |
|||
| ASE-9405 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
 DISC1-/-) Genome edited iPSCs (KO) DISC1-/- |
|||
| ASE-9406 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
 SOD1-/-) Genome edited iPSCs (KO) SOD1-/- |
|||
| ASE-9407 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
 CNTNAP2-/-) Genome edited iPSCs (KO) CNTNAP2-/- |
|||
| ASE-9408 | Applied StemCell | 1 vial (1 x 10^6) | EUR 3087.5 |
|
Description: 12 month |
|||
 Recombinant MAYV Structural polyprotein Protein |
|||
| VAng-Wyb3702-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
|||
 Recombinant MLV Radiation Pol Polyprotein |
|||
| VAng-Lsx0414-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: MLV Radiation Pol Polyprotein, recombinant protein from E. coli. |
|||
 Recombinant CHIKV Non-structural Polyprotein |
|||
| VAng-Lsx0031-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4168 |
|
Description: CHIKV Non-structural Polyprotein, recombinant protein from E. coli. |
|||
Recombinant CHIKV Non-structural Polyprotein |
|||
| VAng-Lsx0031-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2788 |
|
Description: CHIKV Non-structural Polyprotein, recombinant protein from E. coli. |
|||
 Antibody) Mitochondrial Genome Maintenance Exonuclease 1 (MGME1) Antibody |
|||
| abx235168-100ug | Abbexa | 100 ug | EUR 509 |
Mitochondrial Genome Maintenance Exonuclease 1 (MGME1) Antibody |
|||
| 20-abx302859 | Abbexa |
|
|
) HIV-1 Gag-Pol polyprotein Antibody (Biotin) |
|||
| 20-abx106322 | Abbexa |
|
|
) HIV-1 Gag-Pol polyprotein Antibody (FITC) |
|||
| 20-abx107735 | Abbexa |
|
|
) HIV-1 Gag-Pol polyprotein Antibody (HRP) |
|||
| 20-abx109153 | Abbexa |
|
|
 Moloney murine leukemia virus Gag polyprotein Antibody |
|||
| 20-abx110606 | Abbexa |
|
|
 Antibody) Pre-Glycoprotein Polyprotein GP Complex (GPC) Antibody |
|||
| 20-abx319921 | Abbexa |
|
|
 Antibody) RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| 20-abx115306 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| 20-abx318666 | Abbexa |
|
|
 Antibody (HRP)) Mitochondrial Genome Maintenance Exonuclease 1 (MGME1) Antibody (HRP) |
|||
| 20-abx311506 | Abbexa |
|
|
 Antibody (FITC)) Mitochondrial Genome Maintenance Exonuclease 1 (MGME1) Antibody (FITC) |
|||
| 20-abx311507 | Abbexa |
|
|
 Antibody (Biotin)) Mitochondrial Genome Maintenance Exonuclease 1 (MGME1) Antibody (Biotin) |
|||
| 20-abx311508 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| abx237321-100ug | Abbexa | 100 ug | EUR 551 |
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| 20-abx003807 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| abx145095-100ug | Abbexa | 100 ug | EUR 391 |
 Antibody) RecQ-Mediated Genome Instability Protein 2 (RMI2) Antibody |
|||
| 20-abx005864 | Abbexa |
|
|
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| abx029125-400ul | Abbexa | 400 ul | EUR 523 |
RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody |
|||
| abx029125-80l | Abbexa | 80 µl | EUR 286 |
) Moloney murine leukemia virus Gag polyprotein Antibody (HRP) |
|||
| 20-abx109167 | Abbexa |
|
|
 Antibody) HIV-1 Gag-Pol Polyprotein (gag-pol) Antibody |
|||
| 20-abx110593 | Abbexa |
|
|
 Antibody (HRP)) Pre-Glycoprotein Polyprotein GP Complex (GPC) Antibody (HRP) |
|||
| 20-abx319922 | Abbexa |
|
|
 Antibody (FITC)) Pre-Glycoprotein Polyprotein GP Complex (GPC) Antibody (FITC) |
|||
| 20-abx319923 | Abbexa |
|
|
 Antibody (Biotin)) Pre-Glycoprotein Polyprotein GP Complex (GPC) Antibody (Biotin) |
|||
| 20-abx319924 | Abbexa |
|
|
) HIV-1 gag Polyprotein (121-140) |
|||
| H-4776.0500 | Bachem | 0.5mg | EUR 708 |
|
Description: Sum Formula: C86H138N26O34; CAS# [1815618-20-2] |
|||
HIV-1 gag Polyprotein (121-140) |
|||
| H-4776.1000 | Bachem | 1.0mg | EUR 1240 |
|
Description: Sum Formula: C86H138N26O34; CAS# [1815618-20-2] |
|||
 Antibody (HRP)) RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody (HRP) |
|||
| 20-abx311381 | Abbexa |
|
|
 Antibody (FITC)) RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody (FITC) |
|||
| 20-abx311382 | Abbexa |
|
|
 Antibody (Biotin)) RecQ-Mediated Genome Instability Protein 1 (RMI1) Antibody (Biotin) |
|||
| 20-abx311383 | Abbexa |
|
|
 Avian infectious bursal disease virus Structural polyprotein |
|||
| 1-CSB-RP182094V | Cusabio |
|
|
|
Description: Recombinant Avian infectious bursal disease virus Structural polyprotein,partial expressed in E.coli |
|||
) Moloney murine leukemia virus Gag polyprotein (gag) |
|||
| 1-CSB-EP356017MHK | Cusabio |
|
|
|
Description: Recombinant Moloney murine leukemia virus Gag polyprotein(gag) ,partial expressed in E.coli |
|||
Moloney murine leukemia virus Gag polyprotein (gag) |
|||
| 1-CSB-EP356017MHKe0 | Cusabio |
|
|
|
Description: Recombinant Moloney murine leukemia virus Gag polyprotein(gag),partial expressed in E.coli |
|||
) Lassa virus Pre-glycoprotein polyprotein GP complex (GPC) |
|||
| 1-CSB-EP362480LNP2 | Cusabio |
|
|
|
Description: Recombinant Lassa virus Pre-glycoprotein polyprotein GP complex(GPC),partial expressed in E.coli |
|||
 Recombinant Hepatitis C Virus polyprotein, His, E.coli-100ug |
|||
| QP8939-ec-100ug | EnQuireBio | 100ug | EUR 707 |
 Recombinant Hepatitis C Virus polyprotein, His, E.coli-10ug |
|||
| QP8939-ec-10ug | EnQuireBio | 10ug | EUR 326 |
 Recombinant Hepatitis C Virus polyprotein, His, E.coli-1mg |
|||
| QP8939-ec-1mg | EnQuireBio | 1mg | EUR 2303 |
 Recombinant Hepatitis C Virus polyprotein, His, E.coli-200ug |
|||
| QP8939-ec-200ug | EnQuireBio | 200ug | EUR 1115 |
 Recombinant Hepatitis C Virus polyprotein, His, E.coli-500ug |
|||
| QP8939-ec-500ug | EnQuireBio | 500ug | EUR 1514 |
 Recombinant Hepatitis C Virus polyprotein, His, E.coli-50ug |
|||
| QP8939-ec-50ug | EnQuireBio | 50ug | EUR 435 |
 Protein) Recombinant JEV Polyprotein NS5 (aa 2780-3428) Protein |
|||
| VAng-Wyb3462-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3294 |
|
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
|||
Recombinant JEV Polyprotein NS5 (aa 2780-3428) Protein |
|||
| VAng-Wyb3462-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2113 |
|
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
|||
Recombinant JEV Polyprotein NS5 (aa 2780-3428) Protein |
|||
| VAng-Wyb3462-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 573 |
|
Description: Japanese encephalitis virus Polyprotein NS5 protein, recombinant protein. |
|||
) Recombinant MAYV NS polyprotein Protein (aa 1005-1327) |
|||
| VAng-Wyb3703-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4655 |
|
Description: Mayaro virus (strain Brazil) Non-structural polyprotein, recombinant protein. |
|||
Recombinant MAYV NS polyprotein Protein (aa 1005-1327) |
|||
| VAng-Wyb3703-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3034 |
|
Description: Mayaro virus (strain Brazil) Non-structural polyprotein, recombinant protein. |
|||
) Recombinant MAYV Structural polyprotein Protein (aa 807-1242) |
|||
| VAng-Wyb3704-100g | Creative Biolabs | 100 µg | EUR 6897 |
|
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
|||
Recombinant MAYV Structural polyprotein Protein (aa 807-1242) |
|||
| VAng-Wyb3704-10g | Creative Biolabs | 10 µg | EUR 3005 |
|
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
|||
Recombinant MAYV Structural polyprotein Protein (aa 807-1242) |
|||
| VAng-Wyb3704-50g | Creative Biolabs | 50 µg | EUR 4394 |
|
Description: Mayaro virus (strain Brazil) Structural polyprotein, recombinant protein. |
|||
 [His]) Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|||
| VAng-Lsx0591-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3010 |
|
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
|||
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|||
| VAng-Lsx0591-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2039 |
|
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
|||
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|||
| VAng-Lsx0591-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1396 |
|
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
|||
 Rmi1 ELISA Kit| Mouse RecQ-mediated genome instability protein |
|||
| EF015197 | Lifescience Market | 96 Tests | EUR 689 |
 Rmi2 ELISA Kit| Mouse RecQ-mediated genome instability protein |
|||
| EF016112 | Lifescience Market | 96 Tests | EUR 689 |
 RMI1 ELISA Kit| Bovine RecQ-mediated genome instability protein |
|||
| EF011502 | Lifescience Market | 96 Tests | EUR 689 |
 RMI2 ELISA Kit| Bovine RecQ-mediated genome instability protein |
|||
| EF011868 | Lifescience Market | 96 Tests | EUR 689 |
 RMI1 ELISA Kit| chicken RecQ-mediated genome instability protei |
|||
| EF012342 | Lifescience Market | 96 Tests | EUR 689 |
 RMI2 ELISA Kit| chicken RecQ-mediated genome instability protei |
|||
| EF012499 | Lifescience Market | 96 Tests | EUR 689 |
 ELISA Kit) Mouse Mitochondrial Genome Maintenance Exonuclease 1 (MGME1) ELISA Kit |
|||
| abx555625-96tests | Abbexa | 96 tests | EUR 739 |
 ELISA Kit) Human Mitochondrial Genome Maintenance Exonuclease 1 (MGME1) ELISA Kit |
|||
| abx555849-96tests | Abbexa | 96 tests | EUR 739 |
 ELISA Kit (CUS) Chicken POL (Retrovirus- related Pol polyprotein) ELISA Kit (CUS |
|||
| ELI-15361c | Lifescience Market | 96 Tests | EUR 928 |
 Human HERV- K_3q12.3 provirus ancestral Env polyprotein, ERVK5 E |
|||
| ELI-09980h | Lifescience Market | 96 Tests | EUR 824 |
Collectively these information point out that S. mitis contributes to diminished β-lactam susceptibility amongst generally carried pneumococcal serotypes which are related to lengthy carriage length and excessive recombination frequencies. As pneumococcal vaccine programmes mature, inserting growing stress on the pneumococcal inhabitants construction, will probably be vital to observe the affect of antimicrobial resistance HGT from commensal streptococci akin to S. mitis.
